Subsequent to determination of the ERα activating role in DNMTs genes, we evaluated the role of ERα-induced DNMTs up-regulation in acquired drug resistance of breast cancer cells by testing whether alteration of DNMT1 and DNMT3b expression change drug sensitivity of breast cancer cells. The gene discussed is DNMT3B; the disease is breast cancer.